軟組織肉腫に対するPDGFRA抗体
Lillian R Klug1, Michael C Heinrich1
1Portland VA Health Care System and OHSU Knight Cancer Institute, Portland, OR 97239, USA.
Cell
|February 11, 2017
まとめ
Lartruvo (オララトゥマバ) はPDGFRAを標的にする抗体で,第2相試験でドクソルビシン化学療法に添加されると生存率が改善されました. この抗体はPDGFRAキナーゼの活性を抑制し,臨床前がんモデルでは有望であることが示されています.
科学分野:
- 腫瘍学
- 免疫療法
- 分子生物学
背景:
- 血小板由来成長因子受容体アルファ (PDGFRA) は腫瘍の成長に関与しています.
- PDGFRAをターゲットにすることは,腫瘍学における潜在的な治療戦略です.
研究 の 目的:
- PDGFRAを標的とするモノクローナル抗体のオラトゥマブの有効性と安全性を評価する.
- 進んだ軟組織肉腫の患者でドクソルビシン化学療法にオラトゥマブを加える有益性を評価する.
主な方法:
- ランダム化された第2相臨床試験が行われました.
- 患者はドクソルビシン単独投与か,ドクソルビシンとオラトゥマブを併用した投与を受けた.
- 総生存率は主要評価項でした.
主要な成果:
- オララトゥマブをドクソルビシンに追加すると,ドクソルビシン単独と比較して,全生存期間が著しく改善されました.
- オラトゥマバはドクソルビシンと併用すると,管理可能な安全性プロファイルを示した.
- 前臨床試験では,PDGFRAに依存する腫瘍の増殖を抑制することが示された.
結論:
- オラトゥマブとドクソルビシンの併用は,患者の生存に利点をもたらします.
- オラトゥマバはPDGFRA経路を標的とした新しい治療法です.
- これらの発見に基づいてFDAの承認が認められた.
さらに関連する動画
09:06Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
2.0K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
関連する概念動画
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.